Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

A new study in mice shows that tirzepatide—the active ingredient in the popular drugs Mounjaro and Zepbound—not only helps shed pounds but may also slow or reduce the growth of breast cancer tumors ...

Both GLP-1 drugs, semaglutide is the active ingredient in popular weight-loss drug found in Ozempic and Wegovy, while tirzepatide can be found in Mounjaro and Zepbound.

GLP-1 Drugs Can Be Used First for Weight Loss, Says American College of Cardiology — Diet and exercise no longer the main first-line strategies for weight management ...

With dozens of drugs in development, semaglutide and tirzepatide may only be the beginning of next-generation diabetes and weight loss treatments.

One comes mixed with tirzepatide, the active ingredient in Eli Lilly's Zepbound ... including those described as "research use only." "We will continue to take action to stop those who threaten ...

BrightGene beat semaglutide on a blood sugar endpoint, giving momentum as it barrels toward a readout from a head-to-head trial against tirzepatide.